期刊文献+

靶向血管内皮细胞因子受体3小干扰RNA腺病毒表达载体的构建 被引量:3

Construction of the recombinant adenovirus expressing the short interfering RNA targeting vascular endothelia growth factor receptor 3 gene
下载PDF
导出
摘要 目的构建靶向血管内皮细胞因子受体3(VEGFR-3)的小干扰RNA重组腺病毒表达载体。方法将构建的靶向VEGFR-3特异性小干扰RNA真核表达载体pGenesil-siRNA的启动子及siRNA序列克隆入穿梭质粒pAdTrack,将质粒线性化处理后转化入pAdEasy。重组腺病毒载体线性化处理后转染HEK293细胞,包装重组腺病毒,并进行PCR鉴定、病毒滴度测定;扩增后感染结肠癌LoVo细胞并进行Western blotting检测VEGFR-3蛋白的表达。结果双酶切鉴定及测序证实pAdTrack-pG-siRNA及pAd-VEGFR3-siRNA质粒构建正确,扩增纯化测定重组病毒pAd-VEGFR3-siRNA的滴度为5.6×109pfu/mL。病毒感染结肠癌LoVo细胞后测定VEGFR-3蛋白表达明显降低。结论靶向VEGFR-3小干扰RNA的腺病毒载体构建成功。 Objective To construct the recombinant adenovirus expression vector of a short interfering RNA (siRNA) tar- geting Vascular endnthelia growth factor receptor 3 ( VEGFR - 3) gene. Methods The pGenesil - siRNA expression vector promoter and siRNA, which was constructed, were subcloned to pAdTrack shuttle plasmid. The product was iinearized anti recombinated with pAdEasy. After linearization by Pael, the recombinant adenovirus piasmid was transfected into 293 cells for packaging and amplification, then was further identified by PCR analysis. Western blotting was used to detec! the expression of VEGFR -3 protein in the eolorectal cancer cell lines LoVo infected with the adenovirus. Results The pAdTraek-pG - shRNA andpAd - VEGFR3 - siRNA plasmids had been successfully constructed. File titer of the recombinant virus pad -VEGFR3 -siRNA was 5.6 x 10^9pfu/mL after ampiificated and purified. VEGFR -3 protein expression decreased significantly in the eoloreetal cancer LoVo cells lines after infection by the recombinant virus. Conclusion We have suceessfully constructed the recombinant adenovirus pad -VEGFR3 -siRNA targeting VEGFR- 3 gene.
出处 《大连医科大学学报》 CAS 2013年第2期139-142,共4页 Journal of Dalian Medical University
关键词 VEGFR-3基因 RNA干扰 腺病毒 表达载体 VEGFR - 3 RNA interference adenovirus expression vector
  • 相关文献

参考文献1

二级参考文献1

共引文献26

同被引文献18

  • 1Gaya Spolverato,Aslam Ejaz,Nilo Azad,Timothy M Pawlik.Surgery for colorectal liver metastases: The evolution of determining prognosis[J].World Journal of Gastrointestinal Oncology,2013,5(12):207-221. 被引量:7
  • 2Akram Yusup,Hai-Jiang Wang,Azmat Rahmutula,Parhat Sayim,Ze-Liang Zhao,Guo-Qing Zhang.Clinical features and prognosis in colorectal cancer patients with different ethnicities in Northwest China[J].World Journal of Gastroenterology,2013,19(41):7183-7188. 被引量:16
  • 3Trepat X, Chen Z,Jacobson K. Cell migration[J]. Compr Physiol, 2012,2(4): 2369-2392.
  • 4Wietecha MS, Cerny WL, DiPietro LA. Mechanisms of vessel regres?sion: toward an understanding of the resolution of angiogenesis[J] . CUff Top Microbiol Immunol, 2013, 367: 3-32.
  • 5SubramanianJ, Morgensztern D, Govindan R. Vascular endothelial growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer[J]. Clin Lung Cancer, 2010,11(5): 311-319.
  • 6Martins SF, Garcia EA, Luz MA, et al. Clinicopathological correlation and prognostic significance of VEGF -A, VEGF -C, VEGFR-2 and VEGFR-3 expression in colorectal cancer[J]. Cancer Genomics Pro?teomics, 2013,10 (2) : 55 -67.
  • 7Takahashi K, Mizukami H, Saga Y, et al. Suppression of lymph node and lung metastases of endometrial cancer by muscle-mediated expres?sion of soluble vascular endothelial growth factor receptor-3[J]. Canc?er Sci, 2013,104(8):1107-1111.
  • 8Tuppurainen L, Sallinen H, Kokki E, et al. Preclinical safety, toxicolo?gy, and biodistribution study of adenoviral gene therapy with sVEGFR-2 and sVEGFR-3 combined with chemotherapy for ovarian cancer[J]. Hum Gene Ther Clin Dev, 2013, 24 (1 ) : 29-37.
  • 9Matsumoto M, Roufail S, Inder R, et al. Signaling for lymphangiogen?esis via VEGFR -3 is required for the early events of metastasis[J] . Clin Exp Metastasis, 2013,30(6): 819-832.
  • 10Woollard DJ, Opeskin K, Coso S, et al. Differential expression of VEGF ligands and receptors in prostate cancer[J]. Prostate, 2013, 73 (6) : 563-572.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部